No Detail Found!

Role of Qurs Fishar in Hypertension.

Author(s)
Muhammad Amjad Chishti Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Halima Nazar Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Khan Usmanghani Graduate School of Medical & Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Jinnah University for Women, Karachi, Pakistan
Allah Nawaz Graduate School of Medical & Pharmaceutical Sciences, University of Toyama, Toyama, Japan
Abstract
Hypertension rarely present symptoms and it is diagnosed when it has established any complication. Severe hypertension appears as headache, confusion and coma. Qurs Fishar was being used as antihypertensive medicine in alternative system of medicine since many years. In this study small clinical trial conducted to asses potential effect in the treatment of hypertension. Total 30 patients from mild to moderate hypertension were selected in this study from which twelve had anxiety neurosis while eighteen were using other antihypertensive but there was no effect on their blood pressure. After using Qurs Fishar for 4 weeks, 26 cases (86%) demand no other type of drug except Qurs Fishar to keep their blood pressure control and get over the neurosis. Patients found Qurs Fishar better as it has no side effects. Qurs Fishar is a herbal formulation for treatment of hypertension. In present study clinical evaluation of Qurs Fishar was investigated. The drug Qurs Fishar was prescribed to the patients registered at Shif-ul-mulk Memorial Hospital Hamdard University Karachi. They all belong to Surrounding Areas of Gadap town Karachi. The age limit of patients was 25 to 60 years. The response of the treatment on symptomatology of hypertension was analysed. Qurs Fishar was found to be an economical, safe and effective drug for essential hypertension treatment
Publication Details
Page(s) 62-65
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 3, Issue: 1, Year: 2015

Request the full text from PASTIC

References
NakanishiN,LiW,FukudaH,TakatorigeT,SuzukiK,TakaraK., 2003.Multiple risk factor clustering and risk of hypertension in Japanese male office workers,Ind Health 41 327 -31
BasileJN,LacklandDT,BasileJM,RiehleJE,EganBM, 2004.Astatewide primary care approach to cardiovascular risk factor control in high-risk diabetic andnondiabetic patients with hypertension,J Clin Hypertension 6 18 -25
MurrayCJ,LopezAD, 1997.Mortality by cause for eight regions of the world:,Global Burden of Disease Study. Lancet 349 1269 -76
G.Danaei,M. M. Finucane , J. K.,Lin, 1998.global trends in systolic 6,National Health Survey of Pakistan 50 -
AssmannG,CullenP,SchulteH., 1998.The Munster Heart Study (PROCAM): results of follow-up at 8 years,Eur Heart J 83 2 -11
Attisso , M.A.,R.H. , Bunton,J. and Chich,C.V.,WHO, 1983.,Phytopharmacology and Phytotherapy in Traditional Medicine and Health Care Coverage 195 -
Shaligram , S.V.,Panicker , R., 1985.Effect of chronic treatment with Abana on the responsiveness of guinea-pig bronchial musculature to 150 isoprenaline,Journal of J.J. Group of Hospitals and G.M. College 30 37 -
Gowda , N.C.,ChinniahD., 1985.The management of angina pectoris, hypertension and tachycardia with Abana,Probe 25 69 -
0

Citations

0

Downloads

17

Views